Crossmark

Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation

Crossref DOI link: https://doi.org/10.1186/s12974-018-1373-4

Published Online: 2018-12-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kokona, Despina

Ebneter, Andreas

Escher, Pascal

Zinkernagel, Martin S. https://orcid.org/0000-0003-3447-2359
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 27 August 2018

Accepted: 19 November 2018

First Online: 12 December 2018

Ethics approval

: The present study was approved by the local Animal Ethics Committee (Veterinärdienst des Kantons Bern: BE 57/13) and conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

: Not applicable

: D.K. receives grant support from Bayer. A.E. received honoraria from Bayer for lectures. P.E. None. M.Z. holds equity in Novartis and received financial support from Allergan, Bayer, Heidelberg Engineering, Novartis.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.